BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $218,000 | -9.5% | 2,806 | 0.0% | 0.01% | -11.1% |
| Q4 2021 | $241,000 | +7.1% | 2,806 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $225,000 | +10.3% | 2,806 | +11.0% | 0.01% | +12.5% |
| Q2 2021 | $204,000 | -4.2% | 2,529 | -3.7% | 0.01% | -38.5% |
| Q1 2021 | $213,000 | -30.4% | 2,625 | -31.2% | 0.01% | +8.3% |
| Q4 2020 | $306,000 | -0.3% | 3,818 | +0.1% | 0.01% | -7.7% |
| Q3 2020 | $307,000 | -44.7% | 3,816 | -40.8% | 0.01% | -48.0% |
| Q2 2020 | $555,000 | 0.0% | 6,441 | -5.8% | 0.02% | -16.7% |
| Q1 2020 | $555,000 | +142.4% | 6,840 | +149.6% | 0.03% | +172.7% |
| Q4 2019 | $229,000 | -4.6% | 2,740 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $240,000 | +17.6% | 2,740 | +10.0% | 0.01% | +18.2% |
| Q2 2019 | $204,000 | -0.5% | 2,490 | -1.0% | 0.01% | -8.3% |
| Q1 2019 | $205,000 | +1.5% | 2,515 | -4.2% | 0.01% | +9.1% |
| Q3 2018 | $202,000 | -24.3% | 2,625 | -36.0% | 0.01% | -26.7% |
| Q1 2018 | $267,000 | -26.6% | 4,102 | -27.2% | 0.02% | -25.0% |
| Q4 2017 | $364,000 | +0.6% | 5,637 | -2.2% | 0.02% | 0.0% |
| Q3 2017 | $362,000 | +4.3% | 5,762 | +0.6% | 0.02% | 0.0% |
| Q2 2017 | $347,000 | +14.5% | 5,727 | -2.2% | 0.02% | +11.1% |
| Q1 2017 | $303,000 | -16.1% | 5,858 | -28.2% | 0.02% | -21.7% |
| Q4 2016 | $361,000 | -9.3% | 8,158 | -2.5% | 0.02% | -8.0% |
| Q3 2016 | $398,000 | 0.0% | 8,370 | -5.1% | 0.02% | -3.8% |
| Q2 2016 | $398,000 | -20.2% | 8,819 | -27.5% | 0.03% | -21.2% |
| Q1 2016 | $499,000 | +19.7% | 12,162 | +11.4% | 0.03% | +17.9% |
| Q4 2015 | $417,000 | +13.0% | 10,920 | -3.0% | 0.03% | +7.7% |
| Q3 2015 | $369,000 | -54.0% | 11,252 | -2.0% | 0.03% | -49.0% |
| Q2 2015 | $803,000 | +2.2% | 11,477 | 0.0% | 0.05% | +2.0% |
| Q1 2015 | $786,000 | -7.0% | 11,477 | -0.4% | 0.05% | -5.7% |
| Q4 2014 | $845,000 | -1.9% | 11,522 | -4.0% | 0.05% | -7.0% |
| Q3 2014 | $861,000 | -15.9% | 12,004 | -15.2% | 0.06% | -14.9% |
| Q2 2014 | $1,024,000 | -4.5% | 14,164 | -2.7% | 0.07% | -9.5% |
| Q1 2014 | $1,072,000 | +10.4% | 14,559 | +4.2% | 0.07% | +5.7% |
| Q4 2013 | $971,000 | +2.9% | 13,969 | -2.8% | 0.07% | -6.7% |
| Q3 2013 | $944,000 | -11.6% | 14,376 | -6.8% | 0.08% | -14.8% |
| Q2 2013 | $1,068,000 | – | 15,424 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |